Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes (Q40444516)

20 September 2017

title

Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes (English)

1 reference

20 September 2017

0 references

1 reference

Andrea Thompson Da Poian

5

1 reference

20 September 2017

Mauro Sola-Penna

8

0 references

author name string

Débora Dummer Meira

1

1 reference

20 September 2017

Mônica M Marinho-Carvalho

2

1 reference

20 September 2017

Cesar A Teixeira

3

1 reference

20 September 2017

Venício F Veiga

4

1 reference

20 September 2017

Carla Holandino

6

1 reference

20 September 2017

Marta S de Freitas

7

1 reference

20 September 2017

publication date

1 April 2005

1 reference

Molecular Genetics and Metabolism

20 September 2017

published in

1 reference

20 September 2017

volume

84

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

354-362

1 reference

Glycolysis as primary energy source in tumor cell chemotaxis

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Control of glycolytic enzymes through binding to cell structures and by glucose-1,6-bisphosphate under different conditions. The role of Ca2+ and calmodulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Pyruvate kinase as a microtubule destabilizing factor in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Porin interaction with hexokinase and glycerol kinase: Metabolic microcompartmentation at the outer mitochondrial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Calmodulin antagonists and cell energy metabolism in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

The dual effects of Ca2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Sequence of insulin effects on cytoskeletal and cytosolic phosphofructokinase, mitochondrial hexokinase, glucose 1,6-bisphosphate and fructose 2,6-bisphosphate levels, and the antagonistic action of calmodulin inhibitors, in diaphragm muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Insulin rapidly stimulates binding of phosphofructokinase and aldolase to muscle cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Epinephrine modulates cellular distribution of muscle phosphofructokinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Effects of insulin and actin on phosphofructokinase activity and cellular distribution in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Mayaro virus infection alters glucose metabolism in cultured cells through activation of the enzyme 6-phosphofructo 1-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Clotrimazole decreases glycolysis and the viability of lung carcinoma and colon adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Interaction of murine monoclonal subunit-specific antibodies with phosphofructokinase-1 from Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

A radioassay for phosphofructokinase-1 activity in cell extracts and purified enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Decreased glycolytic metabolism contributes to but is not the inducer of apoptosis following IL-3-starvation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

The biological activities of new polyamine derivatives as potential therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Putative therapeutic applications of calmodulin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Calmodulin accelerates the rate of polymerization of human platelet actin and alters the structural characteristics of actin filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.11.012

10.1016/J.YMGME.2004.11.012

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference